Barrington Research Reaffirms Outperform Rating for Henry Schein (NASDAQ:HSIC)

Key Points

• Barrington Research has reaffirmed an outperform rating for Henry Schein (NASDAQ:HSIC) with a price target of $78.00, indicating a potential upside of 21.44% from its previous close.
• Five analysts have rated the stock with a Buy rating while eight have suggested a Hold rating, resulting in a consensus rating of Hold with an average price target of $76.67.
• Henry Schein reported a missed earnings estimate of $1.10 EPS, below the expected $1.19 EPS, but had revenue of $3.24 billion, exceeding analysts' expectations of $3.22 billion.

Henry Schein (NASDAQ:HSIC - Get Free Report)'s stock had its "outperform" rating reiterated by equities researchers at Barrington Research in a research note issued on Wednesday,Benzinga reports. They presently have a $78.00 price target on the stock. Barrington Research's target price would indicate a potential upside of 21.44% from the stock's previous close.

Other equities research analysts also recently issued reports about the company. Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Saturday, October 11th. UBS Group reduced their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a research note on Wednesday, August 6th. Stifel Nicolaus reissued a "hold" rating and issued a $75.00 price objective (down from $80.00) on shares of Henry Schein in a research note on Friday, July 25th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Henry Schein in a research note on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $76.67.

Henry Schein Trading Up 0.5%

Shares of NASDAQ HSIC opened at $64.23 on Wednesday. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a market cap of $7.79 billion, a price-to-earnings ratio of 20.72, a P/E/G ratio of 2.11 and a beta of 0.81. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The business has a fifty day simple moving average of $67.01 and a 200-day simple moving average of $68.56.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion for the quarter, compared to analysts' expectations of $3.22 billion. During the same period in the prior year, the company earned $1.23 earnings per share. The company's revenue for the quarter was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Sell-side analysts predict that Henry Schein will post 4.74 EPS for the current year.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Artisan Partners Limited Partnership raised its stake in shares of Henry Schein by 0.9% during the 2nd quarter. Artisan Partners Limited Partnership now owns 6,462,204 shares of the company's stock worth $472,064,000 after purchasing an additional 55,653 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in shares of Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock valued at $436,489,000 after acquiring an additional 390,399 shares during the last quarter. Ameriprise Financial Inc. increased its holdings in shares of Henry Schein by 3,275.2% during the 2nd quarter. Ameriprise Financial Inc. now owns 2,266,858 shares of the company's stock valued at $165,594,000 after acquiring an additional 2,199,695 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock valued at $153,480,000 after acquiring an additional 103,384 shares during the last quarter. Finally, Burgundy Asset Management Ltd. increased its holdings in shares of Henry Schein by 33.9% during the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock valued at $153,105,000 after acquiring an additional 566,530 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.